Is GHK-Cu FDA-approved?

By The Docket DeskResearched & sourcedUpdated 17 Oct 2026

The short answer

No. GHK-Cu has not been approved as a drug by the FDA. Approval requires full clinical trials and a New Drug Application; GHK-Cu has neither. Its place in 503A Category 1 for non-injectable use is a compounding status, not an approval.

FDA approvalNot approved

Compounding · non-injectable503A Category 1 — within FDA’s interim enforcement policy (not an approval)

Compounding · injectableOn no category list since April 2026 — not authorized

Under FDA reviewPCAC · before end of Feb 2027

Use under reviewNot stated — FDA’s notice names no indication

Earliest pharmacy accessNon-injectable: available now under the interim policy · injectable: late 2027 at the earliest, if cleared

Approved vs compoundable vs “research-use” — the distinction that matters

An FDA-approved drug has cleared full clinical trials. A compoundable substance is one a licensed pharmacy may prepare to prescription, even without full approval, if it sits on the 503A Category 1 list. For GHK-Cu that turns on the route: the FDA’s entry “GHK-Cu (except for injectable routes of administration)” sits in Category 1, so non-injectable GHK-Cu is covered by the FDA’s interim enforcement policy, while injectable GHK-Cu is on no list and is not. Products labeled “for research use only” are not authorized for human use. This page does not provide sourcing, dosing, or preparation guidance.

What “not FDA-approved” means here

EVIDENCE GRADE · MIXED · TOPICAL BETTER-STUDIED THAN INJECTABLE

GHK-Cu has a body of cosmetic and laboratory research for topical skin effects; evidence for injectable systemic use is weaker. Regulatory status changed in April 2026 (see status box).

Will GHK-Cu become legal in 2026?+

The question has two answers. Non-injectable GHK-Cu already sits in 503A Category 1 and may be compounded under the FDA’s interim policy. Injectable GHK-Cu is on no list, and nothing changes for it before the advisory committee meets, due before the end of February 2027. Even a favorable vote there is a recommendation, not a rule.

Is “research-grade” GHK-Cu the same as a medicine?+

No. Material sold “for research use only” is not made or tested to pharmaceutical standards, is not authorized for human use, and carries no guarantee of identity, purity or sterility. This site does not link to or evaluate these sellers.

Primary sources: FDA 503A interim list (Apr 2026 update) · FDA Advisory Committee Calendar; Federal Register docket FDA-2025-N-6895.

Medical & editorial disclaimer. This article is independent reference information, not medical advice and not a recommendation to use any substance. GHK-Cu is not FDA-approved. Nothing here should be used to obtain, prepare, or self-administer any drug. Talk to a licensed clinician about your health. Peptide Docket is not affiliated with the FDA and does not sell peptides.